Cargando…

Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel

BACKGROUND: The majority of new HIV infections are acquired through heterosexual transmission. There is urgent need for prevention methods to compliment behavior change and condom use. Topical microbicide represent a potential strategy for reduction of HIV transmission in women. METHODS: Monthly Col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chirenje, Zvavahera M, Mâsse, Benoît R, Maslankowski, Lisa A, Ramjee, Gita, Coletti, Anne S, Tembo, Tchangani N, Magure, Tsitsi M, Soto-Torres, Lydia, Kelly, Cliff, Hillier, Sharon, Karim, Abdool
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494172/ https://www.ncbi.nlm.nih.gov/pubmed/22944480 http://dx.doi.org/10.7448/IAS.15.2.17376

Ejemplares similares

Microbicides for HIV prevention
por: Ramjee, Gita
Publicado: (2011)

Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa
por: Ramjee, Gita, et al.
Publicado: (2007)

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide
por: Ngandu, Nobubelo K., et al.
Publicado: (2017)

Measuring Dilution of Microbicide Gels with Optical Imaging
por: Drake, Tyler K., et al.
Publicado: (2013)

Vaginal deployment and tenofovir delivery by microbicide gels
por: Gao, Y., et al.
Publicado: (2015)

Microbicides 2006 conference
por: Ramjee, Gita, et al.
Publicado: (2006)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

VivaGel(™) (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection
por: Rupp, Richard, et al.
Publicado: (2007)

South Africa's Experience of the Closure of the Cellulose Sulphate Microbicide Trial
por: Ramjee, Gita, et al.
Publicado: (2007)

Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial
por: Friedland, Barbara A., et al.
Publicado: (2015)

Microbicides 2008 conference: From discovery to advocacy
por: Ramjee, Gita, et al.
Publicado: (2008)

Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection
por: Brouwers, Joachim, et al.
Publicado: (2008)

Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1
por: Li, Liangzhu, et al.
Publicado: (2012)

Quantitative Analysis of Microbicide Concentrations in Fluids, Gels and Tissues Using Confocal Raman Spectroscopy
por: Chuchuen, Oranat, et al.
Publicado: (2013)

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
por: McCormack, Sheena, et al.
Publicado: (2010)

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
por: Succop, Stacey M., et al.
Publicado: (2014)

Microbicides & their implications in HIV prevention
por: Karim, Salim S. Abdool, et al.
Publicado: (2010)

Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use
por: Gafos, Mitzy, et al.
Publicado: (2010)

Acceptability of Carraguard Vaginal Microbicide Gel among HIV-Infected Women in Chiang Rai, Thailand
por: Whitehead, Sara J., et al.
Publicado: (2011)

Acceptability of UC781 Gel as a Rectal Microbicide Among HIV-Uninfected Women and Men
por: Ventuneac, Ana, et al.
Publicado: (2009)

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women
por: McGowan, Ian, et al.
Publicado: (2016)

Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials
por: Miller, Lori, et al.
Publicado: (2021)

Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa
por: Ramjee, Gita, et al.
Publicado: (2007)

Acceptability and Use of the Diaphragm and Replens(®) Lubricant Gel for HIV Prevention in Southern Africa
por: Montgomery, Elizabeth T., et al.
Publicado: (2009)

A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel
por: Schwartz, Jill L., et al.
Publicado: (2011)

Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials
por: Keller, Marla J., et al.
Publicado: (2010)

Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates
por: Girard, Lauren, et al.
Publicado: (2018)

Comparison effect of azithromycin gel 2% with clindamycin gel 1% in patients with acne
por: Mokhtari, Fatemeh, et al.
Publicado: (2016)

Design and validation of a multiplexed low coherence interferometry instrument for in vivo clinical measurement of microbicide gel thickness distribution
por: Drake, Tyler K., et al.
Publicado: (2011)

Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
por: Segarra, Theodore J., et al.
Publicado: (2011)

Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy
por: Massad, L. Stewart, et al.
Publicado: (2023)

The Diaphragm and Lubricant Gel for Prevention of Cervical Sexually Transmitted Infections: Results of a Randomized Controlled Trial
por: Ramjee, Gita, et al.
Publicado: (2008)

Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial
por: Nel, Annaléne, et al.
Publicado: (2018)

Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study
por: Faghihi, Gita, et al.
Publicado: (2016)

Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel
por: Ekama, Sabdat Ozichu, et al.
Publicado: (2021)

Corrigendum to “Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study”
por: Faghihi, Gita, et al.
Publicado: (2017)

A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice
por: Neff, C. Preston, et al.
Publicado: (2011)

Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosa
por: Günaydın, Gökçe, et al.
Publicado: (2019)

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials
por: Mâsse, Benoît R, et al.
Publicado: (2009)

Cell–gel interactions of in-gel propagating bacteria
por: Serwer, Philip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_93dviuo5run0ig4bhb72fg8kip